Implications of BMP9/10 for patients with liver cirrhosis
Open Access
- 3 July 2020
- journal article
- editorial
- Published by Elsevier BV in EBioMedicine
- Vol. 57, 102859
- https://doi.org/10.1016/j.ebiom.2020.102859
Abstract
No abstract availableKeywords
Funding Information
- National Major Science and Technology Projects of China (2018ZX10725–506)
This publication has 10 references indexed in Scilit:
- BMP9/10 in Pulmonary Vascular Complications of Liver DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosisEBioMedicine, 2020
- Hepatopulmonary Syndrome and Portopulmonary Hypertension: Management in Liver Transplantation in the Horizon 2020Transplantation Proceedings, 2020
- Portopulmonary hypertension in the current era of pulmonary hypertension managementJournal of Hepatology, 2020
- Vascular syndromes in liver cirrhosisClinical Journal of Gastroenterology, 2019
- Role of BMP-9 in human liver diseaseGut, 2018
- Review article: Update on current and emergent data on hepatopulmonary syndromeWorld Journal of Gastroenterology, 2018
- Hepatopulmonary Syndrome and Portopulmonary HypertensionClinics in Chest Medicine, 2017
- Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature.2016
- Hepatopulmonary SyndromeClinics in Liver Disease, 2014